NASDAQ:IMMU
Delisted

Immunomedics Stock News

etoro logo Buy IMMU
*Your capital is at risk
$87.86
+0 (+0%)
At Close: May 27, 2022
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector. Surface Oncology Inc (...
Today we offer up an in-depth look at Mersana Therapeutics which recently executed two large ATMs on the same day, raising gross proceeds of $65 million. Interi
Alnylam and Pfizer to discuss how innovative oncology and specialty medicines are transforming commercial models and helping improve patients' lives
Breakouts beyond key levels of resistance suggest that the bulls are in control of the momentum in the biotech sector.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) ADC Therapeutics SA (NYSE:...
Is (IMMU) Outperforming Other Medical Stocks This Year?
In TROPHY U-01 cohort 2, at a median follow-up of 6.8 months, Trodelvy produced an objective response rate (ORR) of 29 percent (95% confidence interval [CI], 12–54) in 21 patients with mUC who were
Q1 2020 Immunomedics Inc Earnings Call
ALMOST half a million teachers have been told to refuse even talking about returning to school next month by the boss of the UK’s biggest teaching union. Boris Johnson is keen for schools to …
Many investors tend to avoid buying stocks that are rising strongly. A healthy dose of patience and skepticism is a sensible approach in the market. However, be
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE